Form 4: Enfusion Director Roy Luo Reports Share Disposal Following Merger Agreement with Clearwater Analytics

Director Roy Luo reports the disposal of Enfusion shares and common units following the merger agreement with Clearwater Analytics, where eligible shares were converted into the right to receive cash or Clearwater Analytics stock.

Summary

• Roy Luo, a director of Enfusion, Inc., filed a Form 4 detailing changes in beneficial ownership.
• The filing reports transactions occurring on April 21, 2025, related to the merger agreement between Enfusion and Clearwater Analytics Holdings, Inc.
• Luo disposed of Class A Common Stock and Common Units of Enfusion Ltd. LLC due to the merger.
• Eligible shares were converted into the right to receive cash or shares of Clearwater Analytics stock.
• The disposed shares include 538,887 Class A Common Stock held directly, 722,707 Class A Common Stock held indirectly by ICONIQ Strategic Partners V, L.P., and 7,748,000 Class A Common Stock held indirectly by ISP V-B EF LP.
• Additionally, 5,030,000 Common Units of Enfusion Ltd. LLC held indirectly by ISP V Main Fund EF LLC were disposed of.
• The consideration for each eligible share was the option of $5.85 in cash, a number of shares of Clearwater Analytics stock equal to the Exchange Ratio, or cash equal to the Aggregate Consideration Per Share.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it primarily reports a transaction related to a merger. There are no explicit positive or negative indicators, but the completion of a merger can be viewed as a significant corporate event.

Future Outlook

The document outlines the completion of a merger agreement, indicating a change in the company's structure and ownership.

Industry Context

This announcement reflects consolidation within the financial technology sector, where companies are merging to expand their service offerings and market reach.

Stakeholder Impact

• Shareholders had the option to receive cash or shares of Clearwater Analytics stock as part of the merger consideration.
• The merger will likely impact employees of Enfusion and Enfusion Ltd. LLC.

Key Dates

Keywords

Enfusion, Clearwater Analytics, Merger, Form 4, Beneficial Ownership, Roy Luo, Share Disposal, Common Units, ICONIQ Capital